OTCMKTS:CANSF Willow Biosciences (CANSF) Stock Price, News & Analysis → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free CANSF Stock Alerts $0.06 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$0.06▼$0.0650-Day Range$0.06▼$0.1052-Week Range$0.05▼$0.11Volume62,000 shsAverage Volume26,097 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Willow Biosciences alerts: Email Address Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. About Willow Biosciences Stock (OTCMKTS:CANSF)Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation. Willow Biosciences Inc. is headquartered in Calgary, Canada.Read More CANSF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CANSF Stock News HeadlinesApril 2, 2024 | markets.businessinsider.comCBG Producer Willow Biosciences Announces Record 43% Revenue Increase And Strategic Moves AheadApril 1, 2024 | proactiveinvestors.comWillow Biosciences expects first commercial revenues in 2024April 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.March 28, 2024 | finance.yahoo.comWILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIFMarch 28, 2024 | prnewswire.comWILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIFMarch 1, 2024 | proactiveinvestors.comWillow Biosciences unveils second strategic investment from KalsecFebruary 29, 2024 | prnewswire.comWILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSECFebruary 22, 2024 | finanznachrichten.deWillow Biosciences Inc.: Willow Biosciences Announces Strategic Investment From Kalsec To Develop Innovative Natural Food IngredientsApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.February 21, 2024 | proactiveinvestors.comWillow Biosciences unveils cash injection for natural ingredients developmentFebruary 20, 2024 | prnewswire.comWILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTSJanuary 31, 2024 | finance.yahoo.comWILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENTJanuary 16, 2024 | finance.yahoo.comWILLOW ANNOUNCES COLLABORATION WITH ENTERIN TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTSJanuary 5, 2024 | theglobeandmail.comClosing Bell: Willow Biosciencesinc up on Friday (WLLW)November 14, 2023 | finance.yahoo.comWILLOW BIOSCIENCES REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEOctober 12, 2023 | theguardian.comAustralian Fashion Laureate awards 2023: Kit X’s Kit Willow warns against ‘crazy’ overconsumptionOctober 10, 2023 | msn.comWillow Springs Garden Haunted Corn Mazes returnOctober 10, 2023 | msn.comSeven injured after taxi van crashes into building in Willow Lawn, driver chargedOctober 9, 2023 | msn.comPolice fatally shoot woman waving a gun at first responders in Willow GroveOctober 8, 2023 | msn.comBuffy The Vampire Slayer: Why Does Willow Turn Evil?October 6, 2023 | msn.comWillow Nightingale Wants To Inspire People Through Hard Work And AuthenticityOctober 6, 2023 | msn.comLafayette Police currently investigating hit and run fatality, West Willow Street closedOctober 5, 2023 | msn.comWillow Smith’s evolving style: From cool tween to stylish rock starOctober 5, 2023 | finance.yahoo.comWillow Bioscience teams again with Suanfarma on large volume anti-infective APIOctober 4, 2023 | msn.comWillow Smith shares stunning Earth, Wind, and Fire coverOctober 3, 2023 | proactiveinvestors.comWillow Biosciences partners Suanfarma to develop large volume anti-infective API through precision fermentationOctober 3, 2023 | finance.yahoo.comWILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATIONSee More Headlines Receive CANSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Willow Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/25/2024Next Earnings (Estimated)5/06/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:CANSF CUSIPN/A CIKN/A Webwww.willowbio.com Phone(403) 910-5140FaxN/AEmployees32Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesDr. Chris SavilePresident, Director & CEOMr. Travis Doupe (Age 52)Chief Financial Officer Comp: $278.4kDr. Trish ChoudharySenior Vice President of Research & DevelopmentMr. Troy T. TalkkariVice President of Corporate DevelopmentMr. Sanjib Singh Gill L.L.B. (Age 48)Corporate Secretary Key Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors CANSF Stock Analysis - Frequently Asked Questions How have CANSF shares performed in 2024? Willow Biosciences' stock was trading at $0.0699 at the beginning of 2024. Since then, CANSF stock has decreased by 7.8% and is now trading at $0.0645. View the best growth stocks for 2024 here. Are investors shorting Willow Biosciences? Willow Biosciences saw a decline in short interest in April. As of April 15th, there was short interest totaling 13,200 shares, a decline of 45.7% from the March 31st total of 24,300 shares. Based on an average daily volume of 8,100 shares, the days-to-cover ratio is currently 1.6 days. View Willow Biosciences' Short Interest. When is Willow Biosciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024. View our CANSF earnings forecast. How do I buy shares of Willow Biosciences? Shares of CANSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CANSF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Goldtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Willow Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
